Who owns ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1?
- CUSIP Number: 02043qab3
Tip: Access positions for across all investors
Analyze quarterly positions in Alnylam Pharmaceuticals Inc Note 1.000 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alnylam Pharmaceuticals Inc Note 1.000 9/1 stock
Who bought or sold ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 170M | $280M | -4% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 25M | $41M | 52% | Sep 2025 |
|
| State Street Corporation | 21M | $35M | 6% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 19M | $31M | 121% | Sep 2025 |
|
| FMR | 17M | $27M | -8% | Sep 2025 |
|
| MacKay Shields | 15M | $25M | -1% | Sep 2025 |
|
| LMR Partners | 15M | $25M | 100% | Sep 2025 |
|
| Parallax Volatility Advisers | 11M | $18M | 100% | Sep 2025 |
|
| Morgan Stanley | 11M | $14M | 100% | Jun 2025 |
|
| BlackRock | 10M | $16M | 1% | Sep 2025 |
|
| Lord, Abbett & Co | 9.8M | $16M | 100% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 4.5M | $7.5M | -69% | Sep 2025 |
|
| SSI Investment Management | 4.1M | $6.7M | -40% | Sep 2025 |
|
| Jpmorgan Chase & Co | 3.3M | $5.4M | -40% | Sep 2025 |
|
| Nicholas Investments Partners | 3.2M | $5.2M | -3% | Sep 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.9M | 50% | Sep 2025 |
|
| Warberg Asset Management | 3.0M | $4.9M | 100% | Sep 2025 |
|
| Franklin Resources | 2.9M | $4.8M | -58% | Sep 2025 |
|
| Wellington Management Company | 2.5M | $4.1M | -86% | Sep 2025 |
|
| Westwood Holdings | 2.1M | $3.5M | -16% | Sep 2025 |
|
| Macquarie Group | 2.1M | $3.4M | -3% | Sep 2025 |
|
| Union Bancaire Privee, UBP SA | 2.0M | $2.8M | -5% | Sep 2025 |
|
| Gabelli Funds | 2.0M | $3.3M | -20% | Sep 2025 |
|
| AXA Investment Managers | 1.4M | $6.2M | 100% | Sep 2025 |
|
| Lazard Asset Management | 980k | $16k | -98% | Sep 2025 |
|
| Agf Management | 950k | $1.6M | 0% | Sep 2025 |
|
| Wells Fargo & Company | 943k | $1.5M | 33% | Sep 2025 |
|
| Bank of New York Mellon | 850k | $1.4M | -50% | Sep 2025 |
|
| Jane Street | 550k | $912k | 100% | Sep 2025 |
|
| Calamos Advisors | 365k | $602k | -99% | Sep 2025 |
|
| Sei Investments | 251k | $413k | 0% | Sep 2025 |
|
| Central Pacific Bank - Trust Division | 224k | $368k | -39% | Sep 2025 |
|
| CNH Partners | 130k | $214k | 100% | Sep 2025 |
|
| Oppenheimer Asset Management | 83k | $136k | 5% | Sep 2025 |
|
| Calamos Wealth Management | 66k | $109k | 2% | Sep 2025 |
|
| Virtus ETF Advisers | 47k | $77k | 0% | Sep 2025 |
|
| Stephens | 24k | $39k | 0% | Sep 2025 |
|
| Russell Investments | 20k | $33k | -96% | Sep 2025 |
|
| Balboa Wealth Partners | 15k | $25k | 0% | Sep 2025 |
|
| Boussard & Gavaudan Investment Management | 13k | $22M | 100% | Sep 2025 |
|
| Stonegate Investment Group | 13k | $21k | 100% | Sep 2025 |
|
| Fifth Third Bancorp | 5.0k | $822k | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 2.0k | $3.3k | 0% | Sep 2025 |
|
| Us Bancorp | 2.0k | $3.3k | 0% | Sep 2025 |
|
| Alken Asset Management | 1.0k | $1.6M | 0% | Sep 2025 |
|
| UBS Group | 670.00 | $1.1k | 103% | Sep 2025 |
|
| Erste Asset Management GmbH | 0 | $0 | -100% | Sep 2025 |
|